Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Assets: 2020-2025

Historic Assets for Biofrontera (BFRI) over the last 4 years, with Sep 2025 value amounting to $15.4 million.

  • Biofrontera's Assets fell 16.75% to $15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.4 million, marking a year-over-year decrease of 16.75%. This contributed to the annual value of $22.1 million for FY2024, which is 20.88% down from last year.
  • Latest data reveals that Biofrontera reported Assets of $15.4 million as of Q3 2025, which was down 23.47% from $20.1 million recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Assets peaked at $55.1 million during Q3 2022, and registered a low of $15.4 million during Q3 2021.
  • In the last 3 years, Biofrontera's Assets had a median value of $21.8 million in 2024 and averaged $24.3 million.
  • In the last 5 years, Biofrontera's Assets skyrocketed by 258.60% in 2022 and then slumped by 45.71% in 2024.
  • Over the past 5 years, Biofrontera's Assets (Quarterly) stood at $53.2 million in 2021, then declined by 4.39% to $50.9 million in 2022, then plummeted by 45.11% to $27.9 million in 2023, then fell by 20.88% to $22.1 million in 2024, then declined by 16.75% to $15.4 million in 2025.
  • Its last three reported values are $15.4 million in Q3 2025, $20.1 million for Q2 2025, and $16.6 million during Q1 2025.